IP Library › Assignment 063736/0279
Patent Assignment
Reel/Frame 063736/0279

Assignment of Assignor's Interest

Recorded: 2023-05-23 Pages: 14
Assignor
BAUDAX BIO, INC.
Executed: 2023-03-29
Assignee
ALKERMES PHARMA IRELAND LIMITED
CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, IRELAND
Covered Properties (10)
Nanoparticulate Compositions Having Lysozyme as a Surface Stabilizer
Patent: 7,459,283 →
Application: 10/357,514 →
Publication: US 2003/0185869
Nanoparticulate meloxicam formulations
Patent: 8,512,727 →
Application: 10/784,900 →
Publication: US 2004/0229038
Nanoparticulate Compositions Having Lysozyme as a Surface Stabilizer
Patent: 8,323,641 →
Application: 12/292,091 →
Publication: US 2009/0074875
Nanoparticulate Meloxicam Formulations
Application: 15/437,534 →
Publication: US 2017/0157061
Nanoparticulate Meloxicam Formulations
Application: 15/950,367 →
Publication: US 2018/0228809
Method of Treating Pain in Elderly Patients with Mild Renal Impairment
Application: 16/297,020 →
Publication: US 2019/0275053
Methods of Administering Intravenous Meloxicam in a Bolus Dose
Application: 16/297,095 →
Publication: US 2019/0275054
Nanoparticulate Meloxicam Formulations
Application: 16/550,239 →
Publication: US 2019/0381062
Methods of Administering Intravenous Meloxicam Pre-Operatively and in Combination with Other Drugs
Application: 17/287,489 →
Publication: US 2021/0386753
Methods of Administering Intravenous Meloxicam in a Bolus Dose
Application: 17/820,783 →
Publication: US 2023/0302008
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Patent Security Agreement (Second Lien) Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0245 →
Patent Security Agreement (First Lien) Sep 29, 2011
From: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
To: MORGAN STANLEY SENIOR FUNDING, INC.
Reel/Frame 026994/0186 →
Change of Name Oct 10, 2012
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 029103/0695 →
Asset Transfer Agreement Oct 10, 2012
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 029108/0426 →
Change of Name Oct 10, 2012
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 029104/0071 →
Assignment of Assignor's Interest Oct 10, 2012
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 029103/0465 →
Release by Secured Party (Second Lien) Oct 12, 2012
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: ALKERMES, INC.; ALKERMES PHARMA IRELAND LIMITED; ALKERMES CONTROLLED THERAPEUTICS INC.
Reel/Frame 029116/0379 →
Property Transfer Agreement Aug 12, 2014
From: ALKERMES PHARMA IRELAND LIMITED
To: ALKERMES SCIENCE ONE LIMITED
Reel/Frame 033522/0048 →
Change of Name Mar 27, 2015
From: ALKERMES SCIENCE ONE LIMITED
To: DARAVITA LIMITED
Reel/Frame 035279/0701 →
Asset Transfer and License Agreement Apr 10, 2015
From: ALKERMES PHARMA IRELAND LIMITED
To: DV TECHNOLOGY LLC
Reel/Frame 035410/0001 →
Business Transfer Agreement Apr 10, 2015
From: DARAVITA LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 035409/0831 →
Security Interest Apr 14, 2015
From: RECRO TECHNOLOGY LLC
To: ORBIMED ROYALTY OPPORTUNITIES II, LP
Reel/Frame 035403/0288 →
Change of Name Apr 16, 2015
From: DV TECHNOLOGY LLC
To: RECRO TECHNOLOGY LLC
Reel/Frame 035446/0904 →
Release of Security Interest Apr 27, 2015
From: MORGAN STANLEY SENIOR FUNDING, INC.
To: DARAVITA LIMITED (F/K/A ALKERMES SCIENCE ONE LIMITED, SUCCESSOR IN INTEREST TO ALKERMES PHARMA IRELAND LIMITED)
Reel/Frame 035505/0696 →
Merger Sep 23, 2016
From: RECRO TECHNOLOGY LLC
To: RECRO GAINESVILLE LLC
Reel/Frame 039841/0365 →
Assignment of Assignor's Interest Oct 5, 2016
From: RECRO GAINESVILLE LLC
To: RECRO IRELAND LIMITED
Reel/Frame 039946/0789 →
Assignment of Assignor's Interest Jul 21, 2017
From: RECRO GAINESVILLE LLC
To: RECRO PHARMA, INC.
Reel/Frame 043067/0111 →
Business Transfer Agreement Jul 21, 2017
From: DARAVITA LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 043288/0719 →
Asset Transfer Agreement Jul 21, 2017
From: ELAN PHARMA INTERNATIONAL LIMITED
To: EDT PHARMA HOLDINGS LIMITED
Reel/Frame 043288/0390 →
Merger Jul 21, 2017
From: RECRO TECHNOLOGY LLC
To: RECRO GAINESVILLE LLC
Reel/Frame 043063/0644 →
Change of Name Jul 21, 2017
From: DV TECHNOLOGY LLC
To: RECRO TECHNOLOGY LLC
Reel/Frame 043296/0667 →
Merger Jul 21, 2017
From: RECRO TECHNOLOGY LLC
To: RECRO GAINESVILLE LLC
Reel/Frame 043060/0408 →
Change of Name Jul 21, 2017
From: ALKERMES SCIENCE ONE LIMITED
To: DARAVITA LIMITED
Reel/Frame 043062/0208 →
Assignment of Assignor's Interest Jul 21, 2017
From: COOPER, EUGENE R.; RYDE, TUULA; PRUITT, JOHN; KLINE, LAURA
To: ELAN PHARMA INTERNATIONAL LTD.
Reel/Frame 043061/0526 →
Change of Name Jul 21, 2017
From: EDT PHARMA HOLDINGS LIMITED
To: ALKERMES PHARMA IRELAND LIMITED
Reel/Frame 043301/0750 →